comparemela.com

Latest Breaking News On - V intravenous - Page 1 : comparemela.com

Largest CIDP Trial Offers Promising Results for Drug Combo

Severity of TRD Predicts Ketamine vs ECT Response

Sub-Q Tocilizumab Gives Durable Long-Term Responses in JIA

Patients with juvenile idiopathic arthritis achieved long-term disease control with subcutaneous tocilizumab treatment, without any new safety concerns, in an LTE study of two trials.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.